These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 35265619)
1. Embryonic Hypotaurine Levels Contribute to Strain-Dependent Susceptibility in Mouse Models of Valproate-Induced Neural Tube Defects. Steele JW; Lin YL; Chen N; Wlodarczyk BJ; Chen Q; Attarwala N; Venkatesalu M; Cabrera RM; Gross SS; Finnell RH Front Cell Dev Biol; 2022; 10():832492. PubMed ID: 35265619 [TBL] [Abstract][Full Text] [Related]
2. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects. Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192 [TBL] [Abstract][Full Text] [Related]
3. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos. Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836 [TBL] [Abstract][Full Text] [Related]
4. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Padmanabhan R; Shafiullah MM Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401 [TBL] [Abstract][Full Text] [Related]
5. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Dawson JE; Raymond AM; Winn LM Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698 [TBL] [Abstract][Full Text] [Related]
6. Teratogenicity of valproate conjugates with anticonvulsant activity in mice. Spiegelstein O; Chatterjie N; Alexander G; Finnell RH Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055 [TBL] [Abstract][Full Text] [Related]
7. NRF2 activation inhibits valproic acid-induced neural tube defects in mice. Piorczynski TB; Lapehn S; Ringer KP; Allen SA; Johnson GA; Call K; Lucas SM; Harris C; Hansen JM Neurotoxicol Teratol; 2022; 89():107039. PubMed ID: 34737154 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Nau H; Hauck RS; Ehlers K Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343 [TBL] [Abstract][Full Text] [Related]
9. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione. Hishida R; Nau H Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382 [TBL] [Abstract][Full Text] [Related]
10. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Tung EW; Winn LM Mol Pharmacol; 2011 Dec; 80(6):979-87. PubMed ID: 21868484 [TBL] [Abstract][Full Text] [Related]
11. Myo-inositol enhances teratogenicity of valproic acid in the mouse. Massa V; Wlodarczyk B; Giavini E; Finnell RH Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884 [TBL] [Abstract][Full Text] [Related]
12. A Shared Pathogenic Mechanism for Valproic Acid and Takla TN; Luo J; Sudyk R; Huang J; Walker JC; Vora NL; Sexton JZ; Parent JM; Tidball AM Cells; 2023 Jun; 12(13):. PubMed ID: 37443734 [TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722 [TBL] [Abstract][Full Text] [Related]